Abstract

The adult brain functions within a well-controlled stable environment, the properties of which are determined by cellular exchange mechanisms superimposed on the diffusion restraint provided by tight junctions at interfaces between blood, brain and cerebrospinal fluid (CSF). These interfaces are referred to as “the” blood–brain barrier. It is widely believed that in embryos and newborns, this barrier is immature or “leaky,” rendering the developing brain more vulnerable to drugs or toxins entering the fetal circulation from the mother. New evidence shows that many adult mechanisms, including functionally effective tight junctions are present in embryonic brain and some transporters are more active during development than in the adult. Additionally, some mechanisms present in embryos are not present in adults, e.g., specific transport of plasma proteins across the blood–CSF barrier and embryo-specific intercellular junctions between neuroependymal cells lining the ventricles. However developing cerebral vessels appear to be more fragile than in the adult. Together these properties may render developing brains more vulnerable to drugs, toxins, and pathological conditions, contributing to cerebral damage and later neurological disorders. In addition, after birth loss of protection by efflux transporters in placenta may also render the neonatal brain more vulnerable than in the fetus.

Highlights

  • Understanding the role of blood–brain barrier mechanisms in normal brain development and possible deleterious effects should these mechanisms be dysfunctional is important from the clinical perspective of whether or not drugs or toxins, once they cross the placenta, may have access to the vulnerable developing brain

  • There is good experimental evidence that this high protein concentration is a result of transcellular transfer of plasma proteins across choroid plexus epithelial cells (Dziegielewska et al, 1980, 1991; Habgood et al, 1992; Knott et al, 1997; Liddelow et al, 2009, 2011a) reinforced by the slow turnover of cerebrospinal fluid (CSF) in the developing brain (Bass and Lundborg, 1973; Johanson and Woodbury, 1974) which would be expected to allow proteins entering the CSF via the choroid plexuses to accumulate to a greater extent than in the adult (Johansson et al, 2008)

  • Recent application of physiological and molecular techniques to the study of specific protein transport in the choroid plexus revealed that the plexus epithelial cells contain a number of receptor-/protein-binding-like molecules that have an affinity for albumin and may be the mechanism by which protein is transferred from blood to CSF (Liddelow et al, 2011b)

Read more

Summary

Barrier mechanisms in the developing brain

It is widely believed that in embryos and newborns, this barrier is immature or “leaky,” rendering the developing brain more vulnerable to drugs or toxins entering the fetal circulation from the mother. New evidence shows that many adult mechanisms, including functionally effective tight junctions are present in embryonic brain and some transporters are more active during development than in the adult. Developing cerebral vessels appear to be more fragile than in the adult. Together these properties may render developing brains more vulnerable to drugs, toxins, and pathological conditions, contributing to cerebral damage and later neurological disorders.

INTRODUCTION
Barriers in the developing brain
APPARENT INCREASED PERMEABILITY OF BARRIERS IN DEVELOPING BRAIN
Fold change
INFLUX MECHANISMS ACROSS BRAIN BARRIERS IN THE DEVELOPING BRAIN
Neutral AAs
Transport function
Array qPCR
CONCLUSION
Human Growth and Developmental
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call